AtriCure, Inc.
ATRC
$33.48
$0.722.20%
| Weiss Ratings | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.03 | |||
| Price History | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -11.55% | |||
| 30-Day Total Return | -17.54% | |||
| 60-Day Total Return | 5.72% | |||
| 90-Day Total Return | 0.90% | |||
| Year to Date Total Return | 10.13% | |||
| 1-Year Total Return | 2.95% | |||
| 2-Year Total Return | -13.51% | |||
| 3-Year Total Return | -41.70% | |||
| 5-Year Total Return | 32.12% | |||
| 52-Week High % Change | -24.01% | |||
| 52-Week Low % Change | 72.97% | |||
| Price | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $43.11 | |||
| 52-Week Low Price | $18.94 | |||
| 52-Week Low Price (Date) | Jun 18, 2024 | |||
| 52-Week High Price (Date) | Jan 29, 2025 | |||
| Valuation | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.60B | |||
| Enterprise Value | 1.56B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.95 | |||
| Earnings Per Share Growth | 44.87% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.32 | |||
| Price/Book (Q) | 3.47 | |||
| Enterprise Value/Revenue (TTM) | 3.34 | |||
| Price | $33.48 | |||
| Enterprise Value/EBITDA (TTM) | -73.08 | |||
| Enterprise Value/EBIT | -38.86 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 47.13M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 513 755 4100 | |||
| Address | 7555 Innovation Way Mason, OH 45040 | |||
| Website | www.atricure.com | |||
| Country | United States | |||
| Year Founded | 2000 | |||
| Profitability | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -8.59% | |||
| Profit Margin | -9.60% | |||
| Management Effectiveness | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -4.09% | |||
| Return on Equity | -- | |||
| Income Statement | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 465.31M | |||
| Total Revenue (TTM) | 465.31M | |||
| Revenue Per Share | $9.87 | |||
| Gross Profit (TTM) | 347.52M | |||
| EBITDA (TTM) | -21.28M | |||
| EBIT (TTM) | -40.01M | |||
| Net Income (TTM) | -44.70M | |||
| Net Income Avl. to Common (TTM) | -44.70M | |||
| Total Revenue Growth (Q YOY) | 16.64% | |||
| Earnings Growth (Q YOY) | -59.04% | |||
| EPS Diluted (TTM) | -0.95 | |||
| EPS Diluted Growth (Q YOY) | -56.74% | |||
| Balance Sheet | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 122.72M | |||
| Cash Per Share (Q) | $2.60 | |||
| Total Current Assets (Q) | 267.83M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 460.97M | |||
| Current Ratio (Q) | 3.648 | |||
| Book Value Per Share (Q) | $9.43 | |||
| Total Assets (Q) | 609.33M | |||
| Total Current Liabilities (Q) | 73.42M | |||
| Total Debt (Q) | 76.53M | |||
| Total Liabilities (Q) | 148.36M | |||
| Total Common Equity (Q) | 460.97M | |||
| Cash Flow | ATRC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 30.23M | |||
| Cash from Financing (TTM) | -3.60M | |||
| Net Change in Cash (TTM) | 38.41M | |||
| Levered Free Cash Flow (TTM) | -10.42M | |||
| Cash from Operations (TTM) | 12.20M | |||
